LUNG DISEASES, INTERSTITIAL
Clinical trials for LUNG DISEASES, INTERSTITIAL explained in plain language.
Never miss a new study
Get alerted when new LUNG DISEASES, INTERSTITIAL trials appear
Sign up with your email to follow new studies for LUNG DISEASES, INTERSTITIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Researchers track Real-World side effects of ofev in lung disease patients
Knowledge-focused OngoingThis study monitors the long-term safety of the drug Ofev in people with systemic scleroderma-associated interstitial lung disease (SSc-ILD) in Japan. It does not test a new treatment but instead collects real-world data on side effects, especially stomach issues like diarrhea an…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 26, 2026 06:09 UTC
-
Firefighter cancer screening study pulled before it began
Knowledge-focused TerminatedThis study planned to give low-dose CT scans to firefighters aged 35 and older to check for lung cancer and other lung diseases caused by job-related smoke and chemical exposure. It aimed to see if screening based on occupation, not just smoking history, could catch cancers earli…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC
-
New study tracks lung function and symptoms in rare lung disease patients on nintedanib
Knowledge-focused OngoingThis study looks at 88 adults with connective tissue disease-related progressive lung scarring who are taking the drug nintedanib. Researchers want to see if changes in lung function over 24 months are linked to changes in cough and shortness of breath. The goal is to better unde…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC